Results 181 to 190 of about 10,879 (228)

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Keshavarz K, Teymourzadeh E, Abyazi MA, Alavian SM, Pouria A.   +6 more
europepmc   +1 more source

Micro-elimination of Hepatitis C virus (HCV) infection in the General Population Cohort in rural Uganda: long-term follow-up to assess feasibility and outcomes of a screening and treatment intervention

Mugisha J, Kimono B, Lumley S, O’Hara G, Waddilove E, Wekesa C, Mgomella G, Makanga R, Ndungutse R, Nyirenda M, Davis C, Thomson E, Ocama P, Seeley J, Matthews PC, Newton R.   +15 more
europepmc   +1 more source

Pharmaceutical industry payments and prescriptions of direct acting antiviral drugs for hepatitis C virus infection. [PDF]

Liver Int
Murayama A, Sigel KM, Tarras ES, Marshall DC.   +3 more
europepmc   +1 more source

Marked Reduction in HIV/HCV Coinfections in Iceland Following the TraP HepC Nationwide Hepatitis C Elimination Program. [PDF]

Open Forum Infect Dis
Hlynsdottir K, Olafsson S, Hernandez UB, Kristjansson M, Gottfredsson M.   +4 more
europepmc   +1 more source

Hepatitis C Management in a Lung Cancer Patient on Checkpoint Inhibition: A Case Report. [PDF]

Cureus
Póvoas D, Garrido P, Moraes-Fontes MF, Manata MJ, Maltez F.   +4 more
europepmc   +1 more source

IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis C. [PDF]

J Infect
O'Brien TR, Witt DJ, Saxena V, Morrissey KG, Chen S, Baker FS, Prokunina-Olsson L, Pfeiffer RM, Lai JB.   +8 more
europepmc   +1 more source

Emerging therapies for HBsAg seroclearance: spotlight on novel combination strategies. [PDF]

Hepatol Int
Hui RW, Fung J, Seto WK, Yuen MF, Mak LY.   +4 more
europepmc   +1 more source

Recommendations for Interpreting Intraerythrocytic Tenofovir Diphosphate and Emtricitabine Triphosphate for HIV-1 Preexposure Prophylaxis Adherence Assessment. [PDF]

J Acquir Immune Defic Syndr
Anderson PL, Coppinger C, Cottrell ML, Marzinke MA.   +3 more
europepmc   +1 more source

Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India. [PDF]

BMC Infect Dis
Bakshi S, Dutta S, Biswas A, Das R, Nath S, Ghosh A, Baskey U, Sadhukhan PC.   +7 more
europepmc   +1 more source

Development and validation of a diagnostic machine learning model for gastric cancer risk based on double-negative T cell-related features. [PDF]

Cancer Cell Int
Yin Z, Zhang G, Yin Z, Ma W, Yang J, Deng W, Feng Z, Wang Z, Jin Y, Zhu Y, Cao K.   +10 more
europepmc   +1 more source